Table 1.
Baseline parameters in both cohorts
| Parameter | HTN | CKD | P-value |
|---|---|---|---|
| Age (years) | 56 ± 10 | 59 ± 14 | 0.34 |
| BMI (kg/m2) | 30.9 ± 5.4 | 28.1 ± 6.7 | 0.13 |
| Peripheral BP (mmHg) | 150/95 ± 17/10 | 141/82 ± 15/10 | 0.04* |
| Mean arterial BP (mmHg) | 112 ± 12 | 101.6 ± 10.2 | 0.002* |
| Creatinine (µmol/L) | 71 ± 11 | 359 ± 274 | <0.001* |
| eGFR (mL/min/1.73m2) | 94.4 ± 11.7 | 22.4 ± 12.6 | <0.001* |
| Angiotensin-converting enzyme inhibitor, n (%) | 9 (45) | 15 (50) | 0.62 |
| Angiotensin receptor blocker, n (%) | 6 (30) | 7 (23) | 0.60 |
| Beta-blocker, n (%) | 3 (15) | 10 (33) | 0.15 |
| Calcium channel blocker, n (%) | 10 (50) | 15 (50) | 1.00 |
| Statin, n (%) | 6 (30) | 16 (53) | 0.10 |
| Allopurinol, n (%) | 2 (10) | 10 (33) | 0.06 |
| Spironolactone, n (%) | 2 (10) | 0 (0) | 0.07 |
| Current smoker, n (%) | 4 (20) | 6 (20) | 0.62 |
*
Indicate a significant difference.